Literature DB >> 24477653

miR-200b as a prognostic factor targets multiple members of RAB family in glioma.

Qing Liu1, Hailin Tang, Xiaoping Liu, Yiwei Liao, Haoyu Li, Zijin Zhao, Xianrui Yuan, Weixi Jiang.   

Abstract

miR-200b is a tumor suppressor in multiple tumors including gastric cancer, breast cancer, ovarian cancer and glioma. In this study, we detected the expression of miR-200b and analyzed its correlation with clinicopathological parameters in glioma tissues. miR-200b was downregulated in glioma tissues. And its downexpression was correlated with poor prognosis in gliomas. Members of RAB family, RAB21, RAB23, RAB18 and RAB3B were predicted to be novel targets of miR-200b. The direct suppression of RAB21, RAB23, RAB18 and RAB3B expressions by miR-200b was revealed by luciferase reporter assay, quantitative RT-PCR analysis and Western blot. Furthermore, the overall survival of patients with different expression of RABs was analyzed. The expression of RAB21, RAB23, RAB18 and RAB3B was related to the prognosis and histopathology of glioma. The patients who had the upregulation of all the four RABs had the worst outcome; those who had the downregulation of all RABs had the best outcome (p<0.001). miR-200b was a potential biomarker for glioma prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477653     DOI: 10.1007/s12032-014-0859-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

1.  The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.

Authors:  Susanna Leskelä; Luis J Leandro-García; Marta Mendiola; Jorge Barriuso; Lucía Inglada-Pérez; Iván Muñoz; Beatriz Martínez-Delgado; Andrés Redondo; Javier de Santiago; Mercedes Robledo; David Hardisson; Cristina Rodríguez-Antona
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

2.  Rab18 and Rab43 have key roles in ER-Golgi trafficking.

Authors:  Selma Y Dejgaard; Ayesha Murshid; Aysegül Erman; Ozge Kizilay; David Verbich; Robert Lodge; Kurt Dejgaard; Thi Bach Nga Ly-Hartig; Rainer Pepperkok; Jeremy C Simpson; John F Presley
Journal:  J Cell Sci       Date:  2008-07-29       Impact factor: 5.285

3.  Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.

Authors:  Xiaona You; Fabao Liu; Tao Zhang; Yinghui Li; Lihong Ye; Xiaodong Zhang
Journal:  Carcinogenesis       Date:  2013-03-07       Impact factor: 4.944

4.  The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Authors:  Manav Korpal; Esther S Lee; Guohong Hu; Yibin Kang
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

5.  Characterization of Rab18, a lipid droplet-associated small GTPase.

Authors:  Sally Martin; Robert G Parton
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

6.  Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer.

Authors:  An Hendrix; Raija Sormunen; Wendy Westbroek; Kathleen Lambein; Hannelore Denys; Gwen Sys; Geert Braems; Rudy Van den Broecke; Veronique Cocquyt; Christian Gespach; Marc Bracke; Olivier De Wever
Journal:  Int J Cancer       Date:  2013-03-07       Impact factor: 7.396

7.  Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.

Authors:  Hirofumi Yoshino; Hideki Enokida; Toshihiko Itesako; Shuichi Tatarano; Takashi Kinoshita; Miki Fuse; Satoko Kojima; Masayuki Nakagawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2013-05-02       Impact factor: 3.172

8.  A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion.

Authors:  S Hooper; C Gaggioli; E Sahai
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

9.  miR-200b targets GATA-4 during cell growth and differentiation.

Authors:  Chun-Xia Yao; Qing-Xia Wei; Yan-Yan Zhang; Wei-Ping Wang; Li-Xiang Xue; Fen Yang; Shu-Feng Zhang; Cheng-Juan Xiong; Wen-Yan Li; Zhi-Ru Wei; Yunzeng Zou; Ming-Xi Zang
Journal:  RNA Biol       Date:  2013-04-01       Impact factor: 4.652

10.  The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells.

Authors:  Maricica Pacurari; Joseph B Addison; Naveen Bondalapati; Ying-Wooi Wan; Dajie Luo; Yong Qian; Vincent Castranova; Alexey V Ivanov; Nancy Lan Guo
Journal:  Int J Oncol       Date:  2013-05-27       Impact factor: 5.650

View more
  18 in total

Review 1.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

2.  MicroRNA-665 suppressed the invasion and metastasis of osteosarcoma by directly inhibiting RAB23.

Authors:  Chenhui Dong; Quanyin Du; Zimin Wang; Yu Wang; Siyu Wu; Aimin Wang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 3.  Rab23 activities and human cancer-emerging connections and mechanisms.

Authors:  Yanan Chen; Fanny Ng; Bor Luen Tang
Journal:  Tumour Biol       Date:  2016-07-23

4.  Effect of Licochalcone-A Combined with Rab23 Gene on Proliferation of Glioma U251 Cells.

Authors:  Yindong Mu; Jianjiang Dong; Hong Cui; Jiangping Hu; Jun Liang; Lei Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-22       Impact factor: 2.650

5.  miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells.

Authors:  Songhua Xiao; Zhen Yang; Ruiyan Lv; Jia Zhao; Ming Wu; Yiwei Liao; Qing Liu
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 6.  The role of the small GTPase Rab31 in cancer.

Authors:  Christelle En Lin Chua; Bor Luen Tang
Journal:  J Cell Mol Med       Date:  2014-12-03       Impact factor: 5.310

7.  MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII.

Authors:  Teng Ma; Yi-Xue Xue
Journal:  Front Mol Neurosci       Date:  2016-02-05       Impact factor: 5.639

Review 8.  MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours.

Authors:  Neha Garg; Thusyanth Vijayakumar; David Bakhshinyan; Chitra Venugopal; Sheila K Singh
Journal:  Stem Cells Int       Date:  2015-05-03       Impact factor: 5.443

9.  miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.

Authors:  Carolini Kaid; Patrícia B G Silva; Beatriz A Cortez; Carolina O Rodini; Patricia Semedo-Kuriki; Oswaldo K Okamoto
Journal:  Cancer Sci       Date:  2015-08-06       Impact factor: 6.716

10.  miR‑367‑3p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells.

Authors:  Wei Du; Dong Li; Jianhao Xie; Ping Tang
Journal:  Oncol Rep       Date:  2021-07-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.